Feature | January 09, 2014

FDA Clears Topera’s Third-Generation 3D Mapping System

System identifies sources that sustain complex cardiac arrhythmias

topera 3-d 3d mapping system firmap rhythmview EP lab mapping fibrillation
January 9, 2014 — Topera Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for the latest generation of its 3D Mapping System. The workstation will be exhibited Jan. 9-11 at the Boston AF Symposium 2014 in Orlando, Fla.
 
The Topera 3D Mapping System consists of the RhythmView Workstation and FIRMap diagnostic catheter.
 
The system provides near-instantaneous intra-procedural mapping and re-mapping capabilities. In addition, the system incorporates a new color-imaging module to aid identification of rotors, an electrophysiological phenomenon previously shown to sustain atrial fibrillation (AF). These functionalities enable EPs to more efficiently diagnose complex arrhythmias.
 
“Atrial fibrillation is an incredibly challenging arrhythmia to treat, and the complexity of this disorder has defied interpretation and visualization by traditional EP mapping approaches,” said Eric Prystowsky, M.D., director of clinical electrophysiology, St. Vincent Hospital, Indianapolis. “Topera’s technology is the first to demonstrate an ability to reflect faithfully the complex mechanism(s) of this arrhythmia and provide a reliable way to visualize the tissue sources sustaining it.”
 
In addition to FDA 510(k) clearance for Topera’s 3D Mapping System, the company also obtained regulatory clearances and launched its proprietary FIRMap panoramic contact-mapping basket catheter in the United States and Europe in late 2013. FIRMap is the first and only contact-mapping basket catheter cleared by the FDA for use in all cardiac chambers to assist in the diagnosis of complex arrhythmias.
 
For more information: www.toperamedical.com, afsymposium.com

Related Content

Charge Density Mapping Eliminates Repeat Ablation for Atrial Fibrillation at One Year
News | EP Mapping and Imaging Systems | July 15, 2019
Acutus Medical announced the publication of the UNCOVER AF study in Circulation: Arrhythmia and Electrophysiology. The...
Innovative Health Receives FDA Clearance to Reprocess Pentaray Nav Eco High-density Mapping Catheter
News | EP Mapping and Imaging Systems | July 05, 2019
Single-use cardiology medical device reprocessing company Innovative Health, received U.S. Food and Drug Administration...
VIVO 3-D Cardiac Mapping System Cleared by FDA
Technology | EP Mapping and Imaging Systems | July 01, 2019
Catheter Precision Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared its new VIVO (View into...
Algorithm Steers Catheters to Right Spot to Treat Atrial Fibrillation

Using human AFib simulations, the researchers demonstrated that their technique can stop the catheter at the right target and identify the source type with a 95.25 percent success rate. This new algorithm also is effective in scarred tissue, which makes ablation more challenging, and has a 99 percent detection rate regardless of the scar size. Image courtesy of Florida Atlantic University.

News | EP Mapping and Imaging Systems | May 28, 2019
Researchers have developed the first algorithm that can locate patient-specific ablation targets for atrial...
Acutus Medical Announces Rhythm Xience Acquisition, New Partnerships at HRS 2019

Acutus Medical's acquisition of Rhythm Xience brings the Flextra steerable introducer sheath into Acutus Medical's product portfolio.

News | EP Mapping and Imaging Systems | May 17, 2019
At the 40th annual Heart Rhythm Scientific Sessions, May 8-11 in San Francisco, Acutus Medical announced the agreement...
Electromechanical Wave Imaging (EWI) is a new, high-frame rate 3-D rendered ultrasound technique that can noninvasively map the electromechanical activation of heart rhythm. This example shows the ECG tracings compared to the EWI image of the heart.

Electromechanical Wave Imaging (EWI) is a new, high-frame rate 3-D rendered ultrasound technique that can noninvasively map the electromechanical activation of heart rhythm. This example shows the ECG tracings compared to the EWI image of the heart.

Feature | EP Mapping and Imaging Systems | May 15, 2019 | Dave Fornell, Editor
May 15, 2019 — A new study shows electromechanical wave imaging is capable of localizing arrhythmias including atrial
Philips and Medtronic Collaborate on Image-guided Atrial Fibrillation Treatment
News | EP Mapping and Imaging Systems | May 09, 2019
Philips announced a collaboration with Medtronic to further advance treatment of paroxysmal atrial fibrillation (PAF),...
Acutus Medical Receives FDA Clearance for Second-generation AcQMap Platform
Technology | EP Mapping and Imaging Systems | April 26, 2019
Acutus Medical announced U.S. Food and Drug Administration (FDA) clearance of its second-generation AcQMap platform,...
Acutus AcQMap Imaging System Helps Eliminate Arrhythmia With Single Ablation
News | EP Mapping and Imaging Systems | January 28, 2019
Acutus Medical announced 12-month data from the UNCOVER-AF trial investigating the use of the AcQMap advanced cardiac...
First Carto Vizigo Bi-Directional Guiding Sheath Employed on West Coast
News | EP Mapping and Imaging Systems | October 29, 2018
October 29, 2018 — Good Samaritan Hospital recently became the first hospital on the West Coast to utilize the Carto
Overlay Init